User profiles for Yu-Lin Lee

Yu-Lin Lee

- Verified email at csh.org.tw - Cited by 1865

Yu Lin (William) Lee

- Verified email at imperial.ac.uk - Cited by 570

Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the …

PL Lu, YC Liu, HS Toh, YL Lee, YM Liu, CM Ho… - International journal of …, 2012 - Elsevier
In 2009, the Study for Monitoring Antimicrobial Resistance Trends (SMART) was expanded
to include surveillance of Gram-negative pathogens causing urinary tract infections (UTIs) in …

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale …

SM Hsieh, MC Liu, YH Chen, WS Lee… - The Lancet …, 2021 - thelancet.com
Background MVC-COV1901, a recombinant protein vaccine containing pre-fusion-stabilised
spike protein S-2P adjuvanted with CpG 1018 and aluminium hydroxide, has been shown …

[HTML][HTML] Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients

YL Lee, CH Liao, PY Liu, CY Cheng… - The Journal of …, 2020 - ncbi.nlm.nih.gov
Liu et al. in this Journal recently reported a COVID-19 patient with prolonged viral shedding
even after seroconversion. 1 The patient’s antibody to SARS-CoV-2 viral nucleocapsid (N) …

[HTML][HTML] Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review

KY Lin, GJ Chen, YL Lee, YC Huang… - World journal of …, 2017 - ncbi.nlm.nih.gov
Hepatitis A virus (HAV) is one of the most common infectious etiologies of acute hepatitis
worldwide. The virus is known to be transmitted fecal-orally, resulting in symptoms ranging from …

[HTML][HTML] Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan

CY Cheng, YL Lee, CP Chen, YC Lin, CE Liu… - Journal of Microbiology …, 2020 - Elsevier
An increase of Ct values was 0.9 per day in 2 cases of COVID-19 treated with lopinavir/ritonavir
(LPV/r), an increase was 1.0 per day in 3 cases without LPV/r through illness day 1–10, …

[HTML][HTML] Carbapenem-resistant Enterobacterales in long-term care facilities: a global and narrative review

HY Chen, SS Jean, YL Lee, MC Lu, WC Ko… - Frontiers in cellular …, 2021 - frontiersin.org
The emergence of carbapenem-resistant Enterobacterales (CRE) has become a major
public health concern. Moreover, its colonization among residents of long-term care facilities (…

Temperature dependences of InxGa1− xN multiple quantum well solar cells

MJ Jeng, YL Lee, LB Chang - Journal of Physics D: Applied …, 2009 - iopscience.iop.org
In this work, high open circuit voltages (V oc) of In 0.2 Ga 0.8 N and In 0.28 Ga 0.72 N
multiple quantum well solar cells (MQWSCs) are experimentally obtained (2.2 V and 1.8 V, …

Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients: Non-albicans candidemia in cancer …

PF Wu, WL Liu, MH Hsieh, IM Hii, YL Lee… - Emerging microbes & …, 2017 - Taylor & Francis
Candidemia is a growing concern worldwide, and its species distribution has shifted toward
non-albicans Candida in recent decades, especially in patients with malignancy. This study …

Geographic patterns of carbapenem-resistant pseudomonas aeruginosa in the Asia-Pacific region: results from the Antimicrobial Testing Leadership And Surveillance …

YL Lee, WC Ko, PR Hsueh - Antimicrobial agents and …, 2022 - Am Soc Microbiol
Pseudomonas aeruginosa is a common pathogen that is associated with multidrug-resistant
(MDR) and carbapenem-resistant (CR) phenotypes; therefore, we investigated its …

An amorphous LiO2-based Li-O2 battery with low overpotential and high rate capability

R Gao, X Liang, P Yin, J Wang, YL Lee, Z Hu, X Liu - Nano Energy, 2017 - Elsevier
Replacing Li 2 O 2 with LiO 2 as the discharge product is a very promising strategy to tackle
the problems of high overpotential (~ 1.5 V), inferior rate capability and short cycle life in the …